Supporting Gut Health with Medical Cannabis: The Gut-Brain Axis and IBS

The gut-brain axis has emerged as a pivotal factor in understanding various gastrointestinal disorders, particularly Irritable Bowel Syndrome (IBS). This bidirectional communication system between the gut and the brain involves complex interactions among the nervous system, immune system, and microbiota. Recent studies have shown that medical cannabis may offer relief and therapeutic benefits for patients living with IBS by modulating the gut-brain axis. In this blog, we explore this further.

What is the Gut-Brain Axis?

The gut-brain axis is a complex communication network that links the emotional and cognitive centers of the brain with peripheral intestinal functions. It involves neural pathways, including the vagus nerve, and hormonal and immune signaling. This axis plays a critical role in maintaining homeostasis and responding to stress, which can significantly impact gastrointestinal health.

Gut Brain Axis and IBS

Irritable Bowel Syndrome and the Gut-Brain Axis

IBS is a common functional gastrointestinal disorder characterised by chronic abdominal pain, bloating, and altered bowel habits. Disruptions in this communication can exacerbate IBS symptoms, making it essential to consider both gut health and mental well-being in treatment strategies.

Psychological stress, altered gut motility, and changes in the gut microbiota can all contribute to the symptoms of IBS.

Medical Cannabis and its Role in Gut Health

Addressing the gut-brain connection offers a holistic approach to IBS management, integrating dietary, probiotic, and psychological therapies to improve patient outcomes. This comprehensive strategy not only targets the gut but also the mental health aspects, providing a more effective solution for those suffering from IBS.

Medical cannabis, contains various terpenes, flavonoids, and cannabinoids, including THC (tetrahydrocannabinol) and CBD (cannabidiol). These compounds interact with the body’s endocannabinoid system (ECS), which plays a crucial rolein regulating gastrointestinal functions such as motility, inflammation, and visceral sensation.

Here are three ways that medical cannabis could assist in treating IBS:

  1. Pain Relief: One of the most debilitating symptoms of IBS is abdominal pain. Medical cannabis, particularly strains high in cannabidiol (CBD) and tetrahydrocannabinol (THC), has been shown to have analgesic properties. A study published highlighted that cannabinoids could modulate gastrointestinal motility and reduce visceral pain, which are key issues in IBS patients.
  2. Anti-Inflammatory Effects: Research demonstrated that CBD exhibits significant anti-inflammatory properties, which can help reduce the intestinal inflammation often seen in IBS. This is particularly beneficial for patients who experience IBS with predominant diarrhoea (IBS-D) as inflammation often contributes to their symptoms.
  3. Stress and Anxiety Reduction: Stress and anxiety are common triggers for IBS flare-ups. Medical cannabis has been noted for its anxiolytic effects, which can help manage the psychological aspects of IBS. By promoting relaxation and reducing anxiety, cannabis can potentially prevent stress-induced IBS symptoms.

Medical cannabis presents a promising avenue for managing IBS symptoms by leveraging the body’s endocannabinoid system. Its potential to alleviate pain, reduce inflammation, ease anxiety, and regulate gut motility makes it a multifaceted treatment option.

Gut Brain Axis and IBS

How can Mamedica help you?

Our doctors work with you to understand the right medical cannabis treatment to help manage your condition and its symptoms effectively.

We offer tailored treatments for various conditions in areas such as pain management, psychiatry, and neurology, which is especially beneficial when dealing with the multiple symptoms of fibromyalgia. Discover the conditions we support here.

To find out if medical cannabis could be an option for you, a loved one, or a patient, take our free eligibility test in under 60 seconds.